You are here:
NICE
NICE Guidance
Conditions and diseases
Cardiovascular conditions
Embolism and thrombosis
Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism
Technology appraisal guidance
Reference number:
TA261
Published:
25 July 2012
Guidance
Tools and resources
Information for the public
Evidence
History
Download guidance (PDF)
Overview
1 Guidance
2 The technology
3 The manufacturer's submission
4 Consideration of the evidence
5 Implementation
6 Recommendations for further research
7 Related NICE guidance
8 Review of guidance
Appendix A: Appraisal Committee members and NICE project team
Appendix B: Sources of evidence considered by the Committee
Changes after publication
About this guidance
Changes after publication
February 2014:
minor maintenance
Next page
About this guidance
Previous page
Appendix B: Sources of evidence considered by the Committee